Skip to main content
Emcure Pharmaceuticals Limited logo

Emcure Pharmaceuticals Limited — Investor Relations & Filings

Ticker · EMCURE ISIN · INE168P01015 LEI · 335800WYB6OIBY9EOZ42 BSE.NS Manufacturing
Open in API
Filings indexed 201 across all filing types
Latest filing 2025-02-06 Regulatory Filings
Country IN India
Listing BSE.NS EMCURE

About Emcure Pharmaceuticals Limited

https://www.emcure.com

Emcure Pharmaceuticals Limited is a research-driven global pharmaceutical organization engaged in the development, manufacturing, and marketing of a broad range of differentiated pharmaceutical products. The company maintains a diverse portfolio across several key therapeutic areas, including gynaecology, cardiovascular, oncology, anti-infectives, and HIV/AIDS. With a strong emphasis on research and development, Emcure operates multiple state-of-the-art manufacturing facilities and R&D centers globally. Its business model focuses on complex generics and innovative formulations, serving healthcare needs in over 70 countries. The company is recognized for its vertically integrated operations and commitment to high-quality standards, catering to both regulated and emerging markets worldwide.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a detailed disclosure under Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. It includes the amended 'Code of Conduct for regulating, monitoring and reporting of Insider trading' and 'Code of Practices and Procedures for fair disclosure of Unpublished Price Sensitive Information' approved by the Board of Directors. The content focuses on insider trading regulations, definitions, compliance officer roles, and procedures related to insider trading and fair disclosure. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory compliance disclosure related to insider trading policies and codes, not a financial report or announcement of financial results. It is not a report publication announcement since it contains the full text of the code and detailed regulatory information. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2025-02-06 English
Integrated Filing- Financial
Regulatory Filings
2025-02-06 English
Financial Result Updates
Regulatory Filings
2025-02-06 English
Outcome of Board Meeting
Regulatory Filings
2025-02-06 English
Action(s) initiated or orders passed
Regulatory Filings Classification · 100% confidence The document is a formal disclosure addressed to stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It reports receipt of a regulatory order from a tax authority (Office of Deputy Commissioner, CGST Audit Commissionerate) concerning a tax demand and penalty for the financial year 2017-18. The document does not contain financial statements or detailed financial analysis but is a regulatory announcement about a legal/regulatory order impacting the company. It is not an annual report, audit report, earnings release, or any other financial report type. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure.
2025-02-05 English
Action(s) initiated or orders passed
Regulatory Filings Classification · 100% confidence The document is a formal disclosure addressed to stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It details regulatory orders received by the company and its subsidiary from a tax authority regarding tax demands, interest, and penalties. The content is a regulatory announcement about legal/tax matters affecting the company, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. The document is a regulatory filing disclosing material regulatory orders as required by listing rules. Therefore, it fits best under Regulatory Filings (RNS). The document length (5104 characters) and content confirm it is not a report publication announcement or certification but a substantive regulatory disclosure.
2025-02-05 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.